TOGA yields 7.36% · JNJ yields 2.13%● Live data
📍 TOGA pulled ahead of the other in Year 1
Combined, TOGA + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of TOGA + JNJ for your $10,000?
TOGA seeks long-term capital appreciation by actively investing in equities of predominantly large- and mid-cap companies around the globe. The fund invests in various developed countries and may also hold equities of emerging market issuers. Typically, the fund allocates at least 40% of its assets to countries outside the US. To build the portfolio, the fund adviser uses a bottom-up, fundamental process, subject to the adviser's discretion. The fundamental approach is based on factors related to strategic business analysis and financial analysis. The selection process tends to favor certain types of firms, which may cause a concentration of investments in a few sectors. The fund seeks a long-term investment horizon. Compounding of returns over multiple years coupled with an ETF structure is expected to result in tax efficiencies. On May 3, 2024, TOGA converted from an unregistered private investment fund to an actively managed ETF structure with about $71 million in assets.
Full TOGA Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.